Nykode Therapeutics to Present at Jefferies Healthcare Conference
OSLO, Norway, May 30, 2023 (GLOBE NEWSWIRE) — Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage…
OSLO, Norway, May 30, 2023 (GLOBE NEWSWIRE) — Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage…
Customers in Eau Claire, Appleton, Monticello, Gays Mills, Clayton, Hartford, Newburg, Fredonia, Oshkosh, Kenosha and,…
With Starter Workflows and Access to “Sifters” Community, Customers Can Start Protecting Their Business From…
Bitdefender Extends its Industry-Leading GravityZone Platform with Advanced, Unified Security for Android, iOS, and Chromebook…
San Diego, California–(Newsfile Corp. – May 30, 2023) – Sonim Technologies (NASDAQ: SONM) today announced…
SHENZHEN, CHINA, May 30, 2023 – (ACN Newswire) – On May 30, China Medical System…
Global Customer Roadshow Features Conversation with Erin Foster and Speakers from Skechers, Mented Cosmetics, Emma–The…
NEW YORK–(BUSINESS WIRE)–$PIPR—Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce…
The fastest and most convenient way for AWS customers to deploy Generative AI REDWOOD CITY,…
ATLANTA–(BUSINESS WIRE)–RM Woodworth & Associates (RMWA), a leading hospitality research and consulting firm, today announced…
May 30, 2023. Wollerau, Switzerland – The Solana Foundation provided a grant for research and…
Davos, Switzerland, May 30th – Runiverse, the leading metaverse game, is thrilled to announce the…
SAN DIEGO, May 30, 2023 (GLOBE NEWSWIRE) — Ambrx Biopharma Inc., or Ambrx (or the…
SAN DIEGO, May 30, 2023 (GLOBE NEWSWIRE) — Ambrx Biopharma Inc., or Ambrx (or the…
LEXINGTON, Mass., May 30, 2023 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the…
LEXINGTON, Mass., May 30, 2023 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the…
As part of the Company’s corporate restructuring plan, Mr. Yaki Baranes will facilitate identifying new…
As part of the Company’s corporate restructuring plan, Mr. Yaki Baranes will facilitate identifying new…
DOYLESTOWN, Pa., May 30, 2023 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the…
DOYLESTOWN, Pa., May 30, 2023 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the…